Orbimed Advisors as of March 31, 2022
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 141 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Springworks Therapeutics (SWTX) | 5.5 | $340M | 6.0M | 56.44 | |
| Horizon Therapeutics Pub L SHS | 3.7 | $231M | 2.2M | 105.21 | |
| Boston Scientific Corporation (BSX) | 3.3 | $204M | 4.6M | 44.29 | |
| Pfizer (PFE) | 3.3 | $202M | 3.9M | 51.77 | |
| Theseus Pharmaceuticals | 3.2 | $197M | 17M | 11.53 | |
| Bristol Myers Squibb (BMY) | 3.1 | $190M | 2.6M | 73.03 | |
| Humana (HUM) | 2.7 | $166M | 382k | 435.17 | |
| Intuitive Surgical Com New (ISRG) | 2.6 | $161M | 534k | 301.68 | |
| UnitedHealth (UNH) | 2.4 | $150M | 294k | 509.97 | |
| Adicet Bio (ACET) | 2.4 | $149M | 7.4M | 19.97 | |
| Abbvie (ABBV) | 2.4 | $148M | 916k | 162.11 | |
| Pmv Pharmaceuticals (PMVP) | 2.3 | $143M | 6.9M | 20.82 | |
| Edgewise Therapeutics (EWTX) | 2.2 | $135M | 14M | 9.70 | |
| Mirati Therapeutics | 2.2 | $134M | 1.6M | 82.22 | |
| BioMarin Pharmaceutical (BMRN) | 2.1 | $127M | 1.6M | 77.10 | |
| Edwards Lifesciences (EW) | 2.0 | $124M | 1.1M | 117.72 | |
| Stryker Corporation (SYK) | 2.0 | $122M | 457k | 267.35 | |
| Arcutis Biotherapeutics (ARQT) | 1.9 | $117M | 6.1M | 19.26 | |
| Iovance Biotherapeutics (IOVA) | 1.8 | $110M | 6.6M | 16.65 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.7 | $104M | 400k | 260.97 | |
| Seagen | 1.6 | $96M | 668k | 144.05 | |
| Keros Therapeutics (KROS) | 1.5 | $91M | 1.7M | 54.38 | |
| Guardant Health (GH) | 1.4 | $88M | 1.3M | 66.24 | |
| Biohaven Pharmaceutical Holding | 1.4 | $85M | 719k | 118.57 | |
| Tricida | 1.4 | $85M | 10M | 8.22 | |
| Neurocrine Biosciences (NBIX) | 1.3 | $82M | 876k | 93.75 | |
| Dex (DXCM) | 1.2 | $77M | 150k | 511.60 | |
| Ikena Oncology Nonvoting | 1.2 | $73M | 12M | 6.10 | |
| Thermo Fisher Scientific (TMO) | 1.2 | $71M | 121k | 590.65 | |
| Natera Call Option (NTRA) | 1.2 | $71M | 1.7M | 40.68 | |
| Si-bone (SIBN) | 1.2 | $71M | 3.1M | 22.60 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.1 | $70M | 3.2M | 21.95 | |
| Prelude Therapeutics (PRLD) | 1.1 | $69M | 10M | 6.90 | |
| Sierra Oncology Com New | 1.0 | $63M | 2.0M | 32.05 | |
| Global Blood Therapeutics In | 0.9 | $56M | 1.6M | 34.64 | |
| Turning Point Therapeutics I | 0.9 | $54M | 2.0M | 26.85 | |
| Tenet Healthcare Corp Com New (THC) | 0.9 | $54M | 628k | 85.96 | |
| Argenx Se Sponsored Adr (ARGX) | 0.9 | $54M | 170k | 315.31 | |
| Xtant Med Hldgs Com New (XTNT) | 0.8 | $50M | 73M | 0.68 | |
| Repare Therapeutics Ord (RPTX) | 0.8 | $47M | 3.3M | 14.24 | |
| Meiragtx Holdings (MGTX) | 0.7 | $46M | 3.3M | 13.85 | |
| Kinnate Biopharma (KNTE) | 0.7 | $46M | 4.0M | 11.26 | |
| Evolent Health Cl A (EVH) | 0.7 | $45M | 1.4M | 32.30 | |
| Abcellera Biologics (ABCL) | 0.7 | $41M | 4.2M | 9.75 | |
| Janux Therapeutics (JANX) | 0.7 | $41M | 2.8M | 14.34 | |
| Nanostring Technologies (NSTGQ) | 0.7 | $40M | 1.2M | 34.75 | |
| Syndax Pharmaceuticals (SNDX) | 0.6 | $38M | 2.2M | 17.38 | |
| Alpine Immune Sciences (ALPN) | 0.6 | $37M | 4.1M | 8.97 | |
| Vaxcyte (PCVX) | 0.6 | $37M | 1.5M | 24.15 | |
| Tela Bio (TELA) | 0.6 | $35M | 3.0M | 11.63 | |
| Neuropace (NPCE) | 0.5 | $33M | 4.0M | 8.21 | |
| Theravance Biopharma (TBPH) | 0.5 | $31M | 3.3M | 9.56 | |
| Silverback Therapeutics (SPRY) | 0.5 | $31M | 8.7M | 3.51 | |
| Compass Therapeutics (CMPX) | 0.5 | $30M | 22M | 1.37 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.5 | $28M | 5.7M | 4.99 | |
| Scpharmaceuticals (SCPH) | 0.4 | $27M | 4.8M | 5.68 | |
| Aclaris Therapeutics (ACRS) | 0.4 | $27M | 1.6M | 17.24 | |
| Gh Research Ordinary Shares (GHRS) | 0.4 | $26M | 1.4M | 18.29 | |
| Vectivbio Hldg Ord Shs | 0.4 | $25M | 5.3M | 4.71 | |
| Fusion Pharmaceuticals (FUSN) | 0.4 | $25M | 3.2M | 7.77 | |
| Biogen Idec (BIIB) | 0.4 | $25M | 118k | 210.60 | |
| Chinook Therapeutics | 0.4 | $23M | 1.4M | 16.36 | |
| Adagio Therapeutics (IVVD) | 0.4 | $23M | 5.1M | 4.56 | |
| Passage Bio (PASG) | 0.4 | $23M | 7.3M | 3.10 | |
| Xenon Pharmaceuticals (XENE) | 0.3 | $21M | 686k | 30.57 | |
| Jounce Therapeutics | 0.3 | $19M | 2.9M | 6.79 | |
| Mereo Biopharma Group Ads (MREO) | 0.3 | $19M | 17M | 1.12 | |
| Mersana Therapeutics (MRSN) | 0.3 | $19M | 4.8M | 3.99 | |
| Gracell Biotechnologies Sponsored Ads | 0.3 | $18M | 7.9M | 2.33 | |
| Ikena Oncology (IKNA) | 0.3 | $18M | 2.9M | 6.10 | |
| Ventyx Biosciences (VTYX) | 0.3 | $18M | 1.3M | 13.57 | |
| Rxsight (RXST) | 0.3 | $17M | 1.4M | 12.38 | |
| Gilead Sciences (GILD) | 0.3 | $17M | 288k | 59.45 | |
| Uniqure Nv SHS (QURE) | 0.3 | $17M | 919k | 18.07 | |
| Milestone Pharmaceuticals (MIST) | 0.3 | $17M | 2.6M | 6.42 | |
| Ultragenyx Pharmaceutical (RARE) | 0.3 | $17M | 228k | 72.62 | |
| Vistagen Therapeutics Com New | 0.3 | $16M | 13M | 1.24 | |
| Illumina (ILMN) | 0.3 | $16M | 45k | 349.40 | |
| Harpoon Therapeutics | 0.2 | $15M | 3.0M | 4.97 | |
| Decibel Therapeutics | 0.2 | $15M | 4.9M | 3.04 | |
| Singular Genomics Systems In (OMIC) | 0.2 | $15M | 2.3M | 6.31 | |
| Synlogic | 0.2 | $15M | 6.0M | 2.40 | |
| Bridgebio Pharma Note 2.250% 2/0 (Principal) | 0.2 | $14M | 30M | 0.48 | |
| Erasca (ERAS) | 0.2 | $14M | 1.7M | 8.60 | |
| Celldex Therapeutics Com New (CLDX) | 0.2 | $14M | 406k | 34.06 | |
| Amgen (AMGN) | 0.2 | $14M | 57k | 241.82 | |
| 89bio (ETNB) | 0.2 | $14M | 3.7M | 3.77 | |
| Burning Rock Biotech Sponsored Ads (BNR) | 0.2 | $14M | 1.5M | 9.29 | |
| Nextcure (NXTC) | 0.2 | $13M | 2.7M | 4.86 | |
| Galapagos Nv Spon Adr (GLPG) | 0.2 | $13M | 208k | 62.02 | |
| Danaher Corporation 5% Conv Pfd B (Principal) | 0.2 | $13M | 8.0k | 1579.30 | |
| Chemomab Therapeutics Sponsored Ads (CMMB) | 0.2 | $12M | 2.6M | 4.80 | |
| Bridgebio Pharma Note 2.500% 3/1 (Principal) | 0.2 | $12M | 20M | 0.60 | |
| Corvus Pharmaceuticals (CRVS) | 0.2 | $11M | 6.9M | 1.64 | |
| Signify Health Cl A Com | 0.2 | $11M | 621k | 18.15 | |
| Terns Pharmaceuticals (TERN) | 0.2 | $11M | 3.8M | 2.97 | |
| Oric Pharmaceuticals (ORIC) | 0.2 | $11M | 2.1M | 5.34 | |
| Pulmonx Corp (LUNG) | 0.2 | $11M | 435k | 24.81 | |
| Alx Oncology Hldgs (ALXO) | 0.2 | $11M | 622k | 16.90 | |
| Bellus Health Com New | 0.2 | $10M | 1.5M | 6.92 | |
| Spdr Ser Tr S&p Biotech (XBI) | 0.2 | $10M | 112k | 89.88 | |
| Aerovate Therapeutics (AVTE) | 0.2 | $9.3M | 510k | 18.33 | |
| Galecto (GLTO) | 0.1 | $9.0M | 4.1M | 2.20 | |
| Cybin Ord (CYBN) | 0.1 | $8.6M | 11M | 0.82 | |
| Imara | 0.1 | $8.2M | 4.4M | 1.88 | |
| Gemini Therapeutics | 0.1 | $8.1M | 5.8M | 1.39 | |
| Graphite Bio | 0.1 | $8.0M | 1.6M | 5.10 | |
| Rapt Therapeutics (RAPT) | 0.1 | $7.9M | 361k | 21.99 | |
| Sonendo (SONX) | 0.1 | $7.9M | 2.0M | 4.01 | |
| Cullinan Oncology (CGEM) | 0.1 | $7.0M | 671k | 10.47 | |
| Aeglea Biotherapeutics | 0.1 | $6.8M | 3.0M | 2.30 | |
| Magenta Therapeutics | 0.1 | $6.5M | 2.3M | 2.90 | |
| 9 Meters Biopharma | 0.1 | $6.2M | 10M | 0.60 | |
| Nanostring Technologies Note 2.625% 3/0 (Principal) | 0.1 | $6.1M | 6.0M | 1.01 | |
| Albireo Pharma | 0.1 | $5.8M | 194k | 29.83 | |
| Logicbio Therapeutics | 0.1 | $5.8M | 8.5M | 0.68 | |
| Cytomx Therapeutics (CTMX) | 0.1 | $5.7M | 2.1M | 2.67 | |
| Chardan Healthcare Acqu- Ord (PHGE) | 0.1 | $5.4M | 2.8M | 1.93 | |
| Oncocyte | 0.1 | $5.2M | 3.5M | 1.49 | |
| Graybug Vision Com Shs | 0.1 | $5.1M | 4.2M | 1.23 | |
| Vor Biopharma (VOR) | 0.1 | $5.0M | 833k | 6.04 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.1 | $4.7M | 1.6M | 2.94 | |
| Protara Therapeutics Com Stk (TARA) | 0.1 | $4.2M | 831k | 5.11 | |
| Immunocore Hldgs Ads (IMCR) | 0.1 | $3.8M | 128k | 29.90 | |
| Acutus Medical (AFIB) | 0.1 | $3.7M | 2.6M | 1.39 | |
| Sarepta Therapeutics (SRPT) | 0.0 | $3.1M | 39k | 78.11 | |
| Vigil Neuroscience (VIGL) | 0.0 | $2.9M | 411k | 7.03 | |
| Talaris Therapeutics | 0.0 | $2.4M | 247k | 9.84 | |
| X4 Pharmaceuticals (XFOR) | 0.0 | $2.4M | 1.4M | 1.75 | |
| Sight Sciences (SGHT) | 0.0 | $2.3M | 200k | 11.56 | |
| I Mab Sponsored Ads (IMAB) | 0.0 | $1.8M | 111k | 16.24 | |
| Exscientia Ads (EXAI) | 0.0 | $1.8M | 125k | 14.40 | |
| Aslan Pharmaceuticals Ads | 0.0 | $1.7M | 1.9M | 0.90 | |
| Aptinyx | 0.0 | $1.2M | 539k | 2.27 | |
| Cabaletta Bio (CABA) | 0.0 | $1.2M | 578k | 2.03 | |
| Field Trip Health Ord | 0.0 | $762k | 577k | 1.32 | |
| Longboard Pharmaceuticals In (LBPH) | 0.0 | $606k | 114k | 5.34 | |
| Mirum Pharmaceuticals (MIRM) | 0.0 | $595k | 27k | 22.04 | |
| Pyxis Oncology Common Stock (PYXS) | 0.0 | $580k | 144k | 4.04 | |
| Landos Biopharma | 0.0 | $418k | 283k | 1.48 | |
| Owlet *w Exp 09/14/202 (OWLTW) | 0.0 | $170k | 221k | 0.77 |
